Cytokinetics reported $623.53M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Acorda Therapeutics ACOR:US $ 80.46M 21.7M
Amgen AMGN:US $ 18520M 865M
Arca Biopharma ABIO:US $ 54.42M 14.31M
Bayer BAYN:GR 38.25B 5.67B
Biogen BIIB:US $ 7915.9M 59.4M
Brainstorm Cell Therapeutics BCLI:US $ 19.26M 4.02M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Capricor Therapeutics CAPR:US $ 59.63M 23.2M
Cytokinetics CYTK:US $ 623.53M 87.85M
Eisai 4523:JP Y 640606M 53549M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Exelixis EXEL:US $ 1842.74M 8M
Genocea Biosciences GNCA:US $ 24.41M 17.41M
Geron GERN:US $ 175.92M 11.28M
Halozyme Therapeutics HALO:US $ 988.69M 62.4M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M